Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 4
2014 4
2016 3
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
The biological weapons threats and coping strategies for health promotion.
Hosseini-Shokouh SJ, Sheikhi RA, Hosseini SMR, Moradimajd P. Hosseini-Shokouh SJ, et al. Among authors: hosseini smr. J Educ Health Promot. 2021 May 20;10:127. doi: 10.4103/jehp.jehp_717_20. eCollection 2021. J Educ Health Promot. 2021. PMID: 34222502 Free PMC article. Review.
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.
Khodaie-Ardakani MR, Mirshafiee O, Farokhnia M, Tajdini M, Hosseini SM, Modabbernia A, Rezaei F, Salehi B, Yekehtaz H, Ashrafi M, Tabrizi M, Akhondzadeh S. Khodaie-Ardakani MR, et al. Among authors: hosseini sm. Psychiatry Res. 2014 Mar 30;215(3):540-6. doi: 10.1016/j.psychres.2013.12.051. Epub 2014 Jan 9. Psychiatry Res. 2014. PMID: 24480077 Clinical Trial.
Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
Hosseini SM, Farokhnia M, Rezaei F, Gougol A, Yekehtaz H, Iranpour N, Salehi B, Tabrizi M, Tajdini M, Ghaleiha A, Akhondzadeh S. Hosseini SM, et al. Eur Neuropsychopharmacol. 2014 Jun;24(6):846-55. doi: 10.1016/j.euroneuro.2014.02.001. Epub 2014 Feb 25. Eur Neuropsychopharmacol. 2014. PMID: 24636461 Clinical Trial.
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia.
Noroozian M, Ghasemi S, Hosseini SM, Modabbernia A, Khodaie-Ardakani MR, Mirshafiee O, Farokhnia M, Tajdini M, Rezaei F, Salehi B, Ashrafi M, Yekehtaz H, Tabrizi M, Akhondzadeh S. Noroozian M, et al. Among authors: hosseini sm. Psychopharmacology (Berl). 2013 Aug;228(4):595-602. doi: 10.1007/s00213-013-3064-2. Epub 2013 Mar 21. Psychopharmacology (Berl). 2013. PMID: 23515583 Clinical Trial.
14 results